PBK and lung cancer: Importantly, Kaplan–Meier survival analyses have shown that higher TOPK expression correlates significantly with a poor prognosis for breast and lung cancer patients, suggesting that TOPK inhibitors can improve the clinical outcome of these patients with high TOPK expression [76].